Nykode Therapeutics AS

OB:NYKD Stock Report

Market Cap: NOK 943.1m

Nykode Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OB:NYKD Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
08 Nov 24BuyNOK 9,585,978Norda ASACompany5,000,000NOK 1.92
08 Nov 24BuyNOK 9,585,978Norda ASACompany5,000,000NOK 1.92
21 Aug 24BuyNOK 282,500Alf Gunnar NicklassonIndividual50,000NOK 5.65
26 Mar 24BuyNOK 374,248Bernd SeizingerIndividual25,000NOK 14.97
21 Mar 24BuyNOK 310,271Birgitte VolckIndividual20,311NOK 15.28
13 Mar 24BuyNOK 139,969Harald GurvinIndividual10,000NOK 14.00
08 Mar 24BuyNOK 370,250Bernd SeizingerIndividual25,000NOK 14.81
08 Mar 24BuyNOK 552,400Alf Gunnar NicklassonIndividual40,000NOK 13.81
04 Mar 24BuyNOK 331,832Harald GurvinIndividual20,000NOK 16.59
29 Feb 24BuyNOK 100,260Michael EngsigIndividual6,000NOK 16.71

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NYKD?
Owner TypeNumber of SharesOwnership Percentage
Public Companies12,996,7553.98%
VC/PE Firms17,815,3115.46%
Individual Insiders54,270,50616.6%
Private Companies70,141,97621.5%
General Public77,892,44123.9%
Institutions93,429,45528.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 70% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.6%
Jan Haudemann-Andersen
41,189,050NOK 119.0m0%no data
9.24%
Rasmussengruppen AS
30,180,750NOK 87.2m0%13.33%
5.46%
RADFORSK
17,815,311NOK 51.5m-26%52.23%
5.42%
Victoria India Fund AS
17,705,175NOK 51.1m0%no data
4.84%
State Street Global Advisors, Inc.
15,818,858NOK 45.7m23.9%no data
4.61%
Capital Research and Management Company
15,050,000NOK 43.5m25.4%no data
3.98%
Norda ASA
12,996,755NOK 37.5m62.5%no data
3.23%
Joh Johannson Eiendom AS
10,561,631NOK 30.5m0%no data
2.29%
Vatne Capital AS
7,485,857NOK 21.6m0%no data
2%
Om Holding AS
6,519,525NOK 18.8m0%no data
1.72%
Handelsbanken Asset Management
5,603,165NOK 16.2m0%no data
1.52%
Simen Thorsen
4,950,000NOK 14.3m0%no data
1.38%
Portia AS
4,500,000NOK 13.0m0%no data
1.37%
Krag Invest As
4,470,100NOK 12.9m0%no data
1.19%
Alden AS
3,900,000NOK 11.3m-7.2%no data
1.06%
JPMorgan Chase & Co, Brokerage and Securities Investments
3,471,645NOK 10.0m0%no data
1.03%
AS Kassiopeia
3,365,000NOK 9.7m0%no data
0.97%
Swedbank Asset Management AS SMB
3,155,150NOK 9.1m0.23%1.2%
0.95%
KLP Kapitalforvaltning AS
3,117,091NOK 9.0m0.52%no data
0.94%
Danske Invest Asset Management AS
3,078,203NOK 8.9m0%0.35%
0.93%
Danske Capital AB
3,043,200NOK 8.8m2.01%0.05%
0.92%
Borgano AS
3,000,000NOK 8.7m0%no data
0.87%
Tore Voldberg
2,850,000NOK 8.2m0%no data
0.73%
Lani Invest As
2,399,916NOK 6.9m0%no data
0.73%
Northern Trust Global Investments
2,368,365NOK 6.8m-2.08%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 08:44
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nykode Therapeutics AS is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Viktor SundbergABG Sundal Collier Sponsored
Geir HolomDNB Markets
Patrick TrucchioH.C. Wainwright & Co.